Genmab A/S (GMAB)
34.36
+1.34
(+4.06%)
USD |
NASDAQ |
Aug 25, 16:00
34.35
-0.01
(-0.03%)
After-Hours: 19:59
Genmab Total Liabilities (Quarterly) : 6.558B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.558B |
| March 31, 2026 | 6.694B |
| December 31, 2025 | 7.026B |
| September 30, 2025 | 1.270B |
| June 30, 2025 | 1.162B |
| March 31, 2025 | 1.290B |
| December 31, 2024 | 1.266B |
| September 30, 2024 | 1.158B |
| June 30, 2024 | 1.099B |
| March 31, 2024 | 605.66M |
| December 31, 2023 | 545.17M |
| September 30, 2023 | 585.81M |
| June 30, 2023 | 472.24M |
| March 31, 2023 | 467.29M |
| December 31, 2022 | 407.16M |
| September 30, 2022 | 530.84M |
| June 30, 2022 | 420.90M |
| March 31, 2022 | 328.33M |
| December 31, 2021 | 371.70M |
| September 30, 2021 | 420.82M |
| June 30, 2021 | 355.79M |
| March 31, 2021 | 334.23M |
| December 31, 2020 | 332.37M |
| September 30, 2020 | 479.70M |
| June 30, 2020 | 423.75M |
| Date | Value |
|---|---|
| March 31, 2020 | 133.07M |
| December 31, 2019 | 164.64M |
| September 30, 2019 | 119.10M |
| June 30, 2019 | 105.40M |
| March 31, 2019 | 91.38M |
| December 31, 2018 | 68.42M |
| September 30, 2018 | 50.55M |
| June 30, 2018 | 53.03M |
| March 31, 2018 | 43.39M |
| December 31, 2017 | 53.34M |
| September 30, 2017 | 68.05M |
| June 30, 2017 | 90.38M |
| March 31, 2017 | 57.44M |
| December 31, 2016 | 58.38M |
| September 30, 2016 | 63.23M |
| June 30, 2016 | 56.69M |
| March 31, 2016 | 59.63M |
| December 31, 2015 | 60.53M |
| September 30, 2015 | 69.12M |
| June 30, 2015 | 76.79M |
| March 31, 2015 | 84.40M |
| December 31, 2014 | 135.49M |
| September 30, 2014 | 152.28M |
| June 30, 2014 | 177.68M |
| March 31, 2014 | 189.66M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AbbVie, Inc. | 141.00B |
| Ascendis Pharma A/S | 971.27M |
| Zealand Pharma A/S | 269.50M |
| Bavarian Nordic A/S | 230.26M |
| Evaxion AS | 9.849M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.51B |
| Shareholders Equity (Quarterly) | 5.957B |
| Debt to Equity Ratio | 0.8852 |
| Current Ratio | 2.457 |
| Net Debt Paydown Yield | -6.26% |